nicotinamide mononucleotide has been researched along with sorafenib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garten, A; Grohmann, T; Kiess, W; Kluckova, K; Lavery, GG; Penke, M | 1 |
1 other study(ies) available for nicotinamide mononucleotide and sorafenib
| Article | Year |
|---|---|
Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Is Reversed by SIRT1.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; Nicotinamide Mononucleotide; Sirtuin 1; Sorafenib | 2019 |